Literature DB >> 1060141

Measurement of cholesterol synthesis in man by isotope kinetics of squalene.

G C Liu, E H Ahrens, P H Schreibman, P Samuel, D J McNamara, J R Crouse.   

Abstract

A method for measuring the rate of total daily cholesterol synthesis in man has been developed through isotope kinetic studies of squalene biosynthesis after intravenous administration of [14C]mevalonic acid. Plasma squalene becomes rapidly labeled, reaching maximal specific activity approximately 100 min after mevalonate administration and then decays exponentially to reach undetectable levels in 12 hr. The rate of daily squalene synthesis equals the percent dose of mevalonate converted to cholesterol divided by the area under the specific activity curve of squalene; the fraction of the dose of mevalonate converted to cholesterol is calculated by the simultaneous injection of [3H]- and [14C] cholesterol in plasma. The premise that squalene and cholesterol synthetic rates are equivalent was tested. In seven patients it was found that the mean daily cholesterol synthesis rates estimated simultaneously by sterol balance and by sqyalene kinetic methods agreed within 8%. In addition, fractional conversions of mevalonic acid to cholesterol were highly correlated with cholesterol synthesis rates. Maximum estimates of the pool sizes and half-lives of metabolically "active" squalene also were obtained. This measurement of daily cholesterol synthesis by squalene kinetics minimizes patient inconvenience, is suitable for outpatient studies, and yields results in 4 weeks or less. Because of the rapidity of the rate of squalene synthesis, the results obtained reflect cholesterol synthesis over a period of less than 10 hr and are therefore uniquely applicable to unsteady state situations.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1060141      PMCID: PMC388773          DOI: 10.1073/pnas.72.11.4612

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL DIETARY AND FECAL NEUTRAL STEROIDS.

Authors:  T A MIETTINEN; E H AHRENS; S M GRUNDY
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

2.  Input-output analysis for total input rate and total traced mass of body cholesterol in man.

Authors:  W Perl; P Samuel
Journal:  Circ Res       Date:  1969-08       Impact factor: 17.367

3.  Thin-layer chromatographic assay for HMG-CoA reductase and mevalonic acid.

Authors:  D J Shapiro; R L Imblum; V W Rodwell
Journal:  Anal Biochem       Date:  1969-10-01       Impact factor: 3.365

4.  Metabolism of mevalonate in rats and man not leading to sterols.

Authors:  A M Fogelman; J Edmond; G Popjåk
Journal:  J Biol Chem       Date:  1975-03-10       Impact factor: 5.157

5.  The interaction of cholesterol absorption and cholesterol synthesis in man.

Authors:  S M Grundy; E H Ahrens; J Davignon
Journal:  J Lipid Res       Date:  1969-05       Impact factor: 5.922

6.  Three-pool model of the long-term turnover of plasma cholesterol in man.

Authors:  D S Goodman; R P Noble; R B Dell
Journal:  J Lipid Res       Date:  1973-03       Impact factor: 5.922

7.  Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotope kinetic and sterol balance methods.

Authors:  S M Grundy; E H Ahrens
Journal:  J Lipid Res       Date:  1969-01       Impact factor: 5.922

8.  Dietary beta-sitosterol as an internal standard to correct for cholesterol losses in sterol balance studies.

Authors:  S M Grundy; E H Ahrens; G Salen
Journal:  J Lipid Res       Date:  1968-05       Impact factor: 5.922

9.  Restraint of cholesterol accumulation in tissue pools associated with drastic short-term lowering of serum cholesterol levels by clofibrate or cholestyramine in hypercholesterolemic swine.

Authors:  D N Kim; K T Lee; J M Reiner; W A Thomas
Journal:  J Lipid Res       Date:  1974-07       Impact factor: 5.922

10.  In vivo studies of sterol and squalene secretion by human skin.

Authors:  T Nikkari; P H Schreibman; E H Ahrens
Journal:  J Lipid Res       Date:  1974-11       Impact factor: 5.922

View more
  8 in total

1.  On determining the extent of side-pool synthesis in a three-pool model for whole body cholesterol kinetics.

Authors:  R Ramakrishnan; R B Dell; D S Goodman
Journal:  J Lipid Res       Date:  1981-11       Impact factor: 5.922

2.  Biliary squalene levels in hepatobiliary disease.

Authors:  Y Nosaka; Y Yamanishi; C Hirayama
Journal:  Gastroenterol Jpn       Date:  1985-08

3.  Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man.

Authors:  T S Parker; D J McNamara; C Brown; O Garrigan; R Kolb; H Batwin; E H Ahrens
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

4.  Role of the kidneys in the metabolism of plasma mevalonate. Studies in humans and in rhesus monkeys.

Authors:  D J McNamara; E H Ahrens; T S Parker; K Morrissey
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

5.  Multicompartmental analysis of cholesterol metabolism in man. Characterization of the hepatic bile acid and biliary cholesterol precursor sites.

Authors:  C C Schwartz; M Berman; Z R Vlahcevic; L G Halloran; D H Gregory; L Swell
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

6.  In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Studies in normal subjects.

Authors:  H J Harwood; D M Bridge; P W Stacpoole
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

7.  Squalene isolation by HPLC and quantitative comparison by HPLC and GLC.

Authors:  J C Sulpice; J Férézou
Journal:  Lipids       Date:  1984-08       Impact factor: 1.880

8.  Measurement of daily cholesterol synthesis rates in man by assay of the fractional conversion of mevalonic acid to cholesterol.

Authors:  D J McNamara; E H Ahrens; P Samuel; J R Crouse
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.